[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370453-105":59,"doc-detail-370453-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","deep-learning-based-identification-of-patients-at-increased-risk-of-cancer-using-routine-laboratory-markers-research-paper","Deep learning-based identification of patients at increased risk of cancer using routine laboratory markers - Research paper","","Early cancer screening improves survival and reduces intensive, costly care from late diagnosis, but population screening requires initial risk stratification to decide who should be tested and how often. This study develops a blood-marker-based risk stratification approach using simple, widely available laboratory tests to flag elevated risk for colorectal, liver, and lung cancers, demonstrating promising ROC performance. It also outlines the role of algorithm deployment and the impact of missing biomarker data in real-world settings.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deep-learning-based-identification-of-patients-at-increased-risk-of-cancer-using-routine-laboratory-markers-research-paper/370453/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deep-learning-based-identification-of-patients-at-increased-risk-of-cancer-using-routine-laboratory-markers-research-paper/370453.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in cancer screening?","Question",{"text":112,"@type":113},"It addresses the need for an initial risk stratification step to determine appropriate screening methods and frequency, aiming to target individuals who benefit most from early diagnosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the proposed approach estimate cancer risk?",{"text":117,"@type":113},"The approach uses routinely available blood tests such as complete blood count and complete metabolic panel to build a risk profile and compute pre- and post-test odds over the next 12 months.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cancers does the study focus on for risk identification?",{"text":121,"@type":113},"It focuses on colorectal, liver, and lung cancers using combinations of simple, widely available laboratory markers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370453,1790915736,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDeep learning-based identification of patients at increased risk of cancer using routine laboratory markers  \nVivek Singh1􀀍, Shikha Chaganti1, Matthias Siebert2, Sowmya Rajesh1, Andrei Puiu3,4, Raj Gopalan5, Jamie Gramz6, Dorin Comaniciu1 & Ali Kamen1  \nEarly screening for cancer has proven to improve the survival rate and spare patients from intensive and costly treatments due to late diagnosis. Cancer screening in the healthy population involves an initial risk stratification step to determine the screening method and frequency, primarily to optimize resource allocation by targeting screening towards individuals who draw most benefit. For most screening programs, age and clinical risk factors such as family history are part of the initial risk stratification algorithm. In this paper, we focus on developing a blood marker-based risk stratification approach, which could be used to identify patients with elevated cancer risk to be encouraged for taking a diagnostic test or participate in a screening program. We demonstrate that the combination of simple, widely available blood tests, such as complete blood count and complete metabolic panel, could potentially be used to identify patients at risk for colorectal, liver, and lung cancers with areas under the ROC curve of 0.76, 0.85, 0.78, respectively. Furthermore, we hypothesize that such an approach could not only be used as pre-screening risk assessment for individuals but also as population health management tool, for example to better interrogate the cancer risk in certain sub-populations.  \nKeywords Oncology screening, Deep learning, Laboratory markers  \nThis paper focuses on the use of multiple biomarkers for the assessment of patients, or identification of otherwise healthy individuals, who are at increased risk of cancer. With the high mortality rate associated with cancer patients, significant research has been conducted to help identify patients at higher risk, starting with identifying medical conditions that increase the risk of cancer, such as diabetes, or genetic predispositions that promote its development1. Furthermore, various screening procedures have been developed to help facilitate early diagnosis such as the Faecal Immunochemical Test (FIT) and colonoscopy for colorectal cancer (CRC)2, mammography for breast cancer3, and low-dose computed tomography (LDCT) for lung cancer4. However, cancer screening rates and their uptake remains lower than desired, e.g., in the US5. While there are several factors contributing to this low uptake, one of the key factors is the lack of awareness within the general population. This is even more important to address for people who may be at increased risk and would benefit from early and/or regular screening. In other words, there is still a need for convenient tests for early detection of rapidly progressing diseases such as cancer so that intervention can start as early as possible6.  \nSeveral cancer risk prediction/assessment tools based on demographic, socioeconomic or blood based markers have been developed over the years, and studies have shown that cancer risk assessment algorithms could have an impact in early cancer diagnosis7. For instance, the Qcancer 10 year risk algorithm8 considers the age, ethnicity, deprivation, body mass index, smoking, alcohol, previous cancer diagnoses, family history of cancer, relevant comorbidities, and medication data for a patient and predicts the cancer risk for 11 types of cancers. Nartowt et al.9 reported high concordance in the prediction ofCRC into low, medium and high groups using an artificial neural network trained on patient data comprising age, sex, and complete blood count (CBC) . ColonFlag10 can be used to identify individuals at high risk ofCRC using specific blood-based markers and refer them to screening procedures such as colonoscopy. More recently, a cell-free DNA-based blood test for the ear","cbCaioJ3wdT6O3Ua","https://ap.wps.com/l/cbCaioJ3wdT6O3Ua","pdf",5215352,13,"English","# Introduction\n## Screening and risk stratification needs\n## Blood-marker-based risk assessment approach\n## Background on existing prediction and screening tools\n## Algorithm deployment and communication","[{\"question\":\"What problem does the study address in cancer screening?\",\"answer\":\"It addresses the need for an initial risk stratification step to determine appropriate screening methods and frequency, aiming to target individuals who benefit most from early diagnosis.\"},{\"question\":\"How does the proposed approach estimate cancer risk?\",\"answer\":\"The approach uses routinely available blood tests such as complete blood count and complete metabolic panel to build a risk profile and compute pre- and post-test odds over the next 12 months.\"},{\"question\":\"Which cancers does the study focus on for risk identification?\",\"answer\":\"It focuses on colorectal, liver, and lung cancers using combinations of simple, widely available laboratory markers.\"}]","Deep learning-based identification of patients at increased risk of cancer using routine laboratory markers - Research paper | PDF",1790188589,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/496ab4c3db641279e6e9f818d894b122.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a787dc5f93644ac0f5f1b0ac15d3a774.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffc3196011de10365073e22d4d2f6f93.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19a94b18e8601e2a412f9dd71f229689.webp",980,1287]